Cryptocurrency Analysis and News Portal
The increasing rise in COVID-19 cases may further stir a boost in the demand for Remdesivir despite the WHO claims.The result of a recent study conducted by the World Health Organization (WHO) on Remdesivir has indicated that the notorious COVID-19 drug may not be as effective in reducing mortality rates
Read More
Gilead Sciences (GILD) stock price has risen on the news that Remdesivir saves more lives than it was previously thought. These results were revealed in a preliminary study.Gilead Sciences Inc (NASDAQ: GILD) stock price has risen 2% on encouraging news on its wonder coronavirus drug Remdesivir. Sources say that new
Read More
Gilead Sciences (GILD) stock is slightly down despite the progress that the company made in testing of its remdesivir drug that can be used as the coronavirus treatment.Shares of Gilead Sciences Inc (NASDAQ: GILD) slightly dropped yesterday despite the company announcing advancement in its race for a COVID-19 treatment. GILD
Read More